Impact of COVID-19 on clinical manifestations, diagnosis, treatment outcome and immune response for pulmonary tuberculosis
- Funded by BRICS
- Total publications:0 publications
Grant number: 051 - ABRICOT
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
BRICSPrincipal Investigator
Valeria Cavalcanti Rolla, Subash Babu, Bavesh KanaResearch Location
Brazil, India, South AfricaLead Research Institution
Oswaldo Cruz Foundation, National Institute for Research in Tuberculosis, ICMR, University of the WitwatersrandResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified